Anders Åhlin

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF AUTOIMMUNITY. 2015;62:39-44
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency
van Schaarenburg RA; Schejbel L; Truedsson L; Topaloglu R; Al-Mayouf SM; Riordan A; Simon A; Kallel-Sellami M; Arkwright PD; Ahlin A; Hagelberg S; Nielsen S; Shayesteh A; Morales A; Tam S; Genel F; Berg S; Ketel AG; van den Berg JM; Kuijpers TW; Olsson RF; Huizinga TWJ; Lankester AC; Trouw LA
Article: ACTA PAEDIATRICA. 2013;102(11):1087-1094
Chronic granulomatous disease - haematopoietic stem cell transplantation versus conventional treatment
Ahlin A; Fugelang J; de Boer M; Ringden O; Fasth A; Winiarski J
Article: GENES AND IMMUNITY. 2011;12(8):626-634
Molecular basis of hereditary C1q deficiency-revisited: identification of several novel disease-causing mutations
Schejbel L; Skattum L; Hagelberg S; Ahlin A; Schiller B; Berg S; Genel F; Truedsson L; Garred P
Article: AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2009;297(3):C621-C631
Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease
Sanmun D; Witasp E; Jitkaew S; Tyurina YY; Kagan VE; Ahlin A; Palmblad J; Fadeel B
Article: PLOS ONE. 2009;4(4):e5234
Chronic granulomatous disease: the European experience.
van den Berg JM; van Koppen E; Ahlin A; Belohradsky BH; Bernatowska E; Corbeel L; Español T; Fischer A; Kurenko-Deptuch M; Mouy R; Petropoulou T; Roesler J; Seger R; Stasia M-J; Valerius NH; Weening RS; Wolach B; Roos D; Kuijpers TW
Article: HUMAN MUTATION. 2006;27(12):1218-1229
Chronic granutomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47^phox component of the phagocyte NADPH oxidase
Roos D; de Boer M; Koker MY; Dekker J; Singh-Gupta V; Ahlin A; Palmblad J; Sanal O; Kurenko-Deptuch M; Jolles S; Wolach B
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2004;126(1):127-132
Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia
Carlsson G; Åhlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Article: INFLAMMATION. 2004;28(3):133-138
Abberant cytosolic calcium ion mobilization in chronic granulomatous disease neutrophils
Palmblad J; Hansson A; Heimbürger M; Åhlin A
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2000;8(9):697-703
A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease.
Meischl C; Boer M; Ahlin A; Roos D
Article: BLOOD. 2000;95(2):666-673
Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
Article: CLINICAL AND VACCINE IMMUNOLOGY. 1999;6(3):420-424
Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils
Åhlin A; Lärfars G; Elinder G; Palmblad J; Gyllenhammar H
Article: BLOOD. 1998;92(12):4808-4818
Involvement of caspases in neutrophil apoptosis:: Regulation by reactive oxygen species
Fadeel B; Åhlin A; Henter JI; Orrenius S; Hampton MB
Article: BLOOD. 1997;89(9):3396-3401
Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients
Ahlin A; Elinder G; Palmblad J
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 1996;184(4):1243-1249
Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease
Leusen JHW; deKlein A; Hilarius PM; Ahlin A; Palmblad J; Smith CIE; Diekmann D; Hall A; Verhoeven AJ; Roos D
Article: ACTA PAEDIATRICA. 1995;84(12):1386-1394
Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden
Ahlin A; DeBoer M; Roos D; Leusen J; Smith CIE; Sundin U; Rabbani H; Palmblad J; Elinder G
Article: TRANSLATIONAL RESEARCH. 1995;125(3):392-401
NEUTROPHIL MEMBRANE-POTENTIAL CHANGES AND HOMOTYPIC AGGREGATION KINETICS ARE PH-DEPENDENT - STUDIES OF CHRONIC GRANULOMATOUS-DISEASE
AHLIN A; GYLLENHAMMAR H; RINGERTZ B; PALMBLAD J

Alla övriga publikationer

Review: CURRENT OPINION IN HEMATOLOGY. 2015;22(1):41-45
Chronic granulomatous disease - conventional treatment vs. hematopoietic stem cell transplantation: an update
Ahlin A; Fasth A
Review: LAKARTIDNINGEN. 2005;102(14):1036-1041
[Chronic granulomatous disease--not only the lack of oxygen radicals].
Palmblad J; Gyllenhammar H; Bratt J; Ahlin A
Review: BLOOD. 1996;87(5):1663-1681
Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease
Roos D; deBoer M; Kuribayashi F; Meischl C; Weening RS; Segal AW; Ahlin A; Nemet K; Hossle JP; BernatowskaMatuszkiewicz E; MiddletonPrice H

Anställningar

Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2027

Examina och utbildning

Docent, pediatrik, Karolinska Institutet, 2016

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI